Towards a cancer mission in Horizon Europe: recommendations

A comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research–care–prevention continuum has the potential to achieve in 2030 a 10‐year cancer‐specific survival for 75% of patients diagnosed in European Union (EU) member...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Mol Oncol
Κύριοι συγγραφείς: Berns, Anton, Ringborg, Ulrik, Celis, Julio E., Heitor, Manuel, Aaronson, Neil K., Abou‐Zeid, Nancy, Adami, Hans‐Olov, Apostolidis, Kathi, Baumann, Michael, Bardelli, Alberto, Bernards, René, Brandberg, Yvonne, Caldas, Carlos, Calvo, Fabien, Dive, Caroline, Eggert, Angelika, Eggermont, Alexander, Espina, Carolina, Falkenburg, Frederik, Foucaud, Jérôme, Hanahan, Douglas, Helbig, Ulrike, Jönsson, Bengt, Kalager, Mette, Karjalainen, Sakari, Kásler, Miklós, Kearns, Pamela, Kärre, Klas, Lacombe, Denis, de Lorenzo, Francesco, Meunier, Françoise, Nettekoven, Gerd, Oberst, Simon, Nagy, Péter, Philip, Thierry, Price, Richard, Schüz, Joachim, Solary, Eric, Strang, Peter, Tabernero, Josep, Voest, Emile
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2020
Θέματα:
Policy Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400777/
https://ncbi.nlm.nih.gov/pubmed/32749074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12763
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια